Data as of Apr 17
| +0.11 / +3.47%|
The 3 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 9.00. The median estimate represents a +204.88% increase from the last price of 3.28.
The current consensus among 3 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.